Mojtabai Ramin
Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore (e-mail:
Psychiatr Serv. 2017 Jul 1;68(7):724-726. doi: 10.1176/appi.ps.201600320. Epub 2017 Mar 15.
The 2016 recommendation statement by the U.S. Preventive Services Task Force (USPSTF) endorsed screening for depression in the general adult population. The recommendation was mainly based on studies that compared enhanced depression care that included depression screening with usual care. In contrast to the USPSTF recommendation, the 2013 guidelines from the Canadian Task Force on Preventive Health Care (CTFPHC) recommended against routine depression screening. The CTFPHC could not identify any studies comparing depression outcomes of usual care with and without the addition of routine depression screening. In the absence of evidence of clinical benefit, there are concerns that wide adoption of the USPSTF recommendation for universal depression screening would lead to overdiagnosis of depression and an increase in inappropriate prescription of antidepressant medications.
美国预防服务工作组（USPSTF）2016年的推荐声明认可对普通成年人群进行抑郁症筛查。该推荐主要基于一些研究，这些研究比较了包括抑郁症筛查在内的强化抑郁症护理与常规护理。与USPSTF的推荐形成对比的是，加拿大预防保健工作组（CTFPHC）2013年的指南不建议进行常规抑郁症筛查。CTFPHC未能找到任何比较添加或不添加常规抑郁症筛查的常规护理的抑郁症结局的研究。在缺乏临床获益证据的情况下，有人担心广泛采用USPSTF的普遍抑郁症筛查推荐会导致抑郁症的过度诊断以及抗抑郁药物不适当处方的增加。
